Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Enfuvirtide (Fuzeon) for HIV infection

Article Abstract:

Clinical testing reveals that inclusion of the fusion inhibitor enfuvirtide (Fuzeon) to an antiretroviral regimen enhances the effectiveness of treatment. It is administered twice subcutaneously, which causes local pain, erythema, induration, nodules and cysts. It is active against HIV strains resistant to other antiretrovirals. It is FDA approved.

Publisher: Medical Letter, Inc.
Publication Name: Medical Letter on Drugs and Therapeutics
Subject: Health
ISSN: 0025-732X
Year: 2003
Enzyme Inhibitors, Physiological aspects, HIV infection, HIV infections, HIV (Viruses), HIV, Antiviral agents, Antiretroviral agents

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Insect repellents

Article Abstract:

Clinical testing reveals that insect repellents containing N,N-diethylmetatoluamide (DEET), particularly the extended duration types, are safe and prevent mosquito and tick bites. Research further indicates that picaridin of foreign origin is as effective as DEET and does not damage clothing and skin. Permethrin for lice is also evaluated.

Publisher: Medical Letter, Inc.
Publication Name: Medical Letter on Drugs and Therapeutics
Subject: Health
ISSN: 0025-732X
Year: 2003
Pesticide and Other Agricultural Chemical Manufacturing, Agricultural chemicals, not elsewhere classified, Insect Repellants & Attractants, Usage, Insect baits and repellents, Insect repellents, Permethrin, Diethyltoluamide, DEET (Diethyltoluamide)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Ophthalmic cyclosporine (Restasis) for dry eye disease

Article Abstract:

Clinical testing reveals that cyclosporine 0.05% ophthalmic emulsion seem to improve symptoms and increase tear production in some patients with dry eye disease. Data indicate that post-treatment blood levels are undetectable making Restasis safe but causes transient burning and stinging in treated eyes. It is FDA approved.

Publisher: Medical Letter, Inc.
Publication Name: Medical Letter on Drugs and Therapeutics
Subject: Health
ISSN: 0025-732X
Year: 2003
Ophthalmic Drugs, Cyclosporine, Cyclosporins, Ophthalmic agents, Dry eye syndromes

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Research, United States, Evaluation, Testing, Drug therapy, Clinical trials
Similar abstracts:
  • Abstracts: Urea kinetics: comparison of oral and intravenous dose regimens. Urea kinetics varies in Jamaican women and men in relation of adiposity, lean body mass and protein intake
  • Abstracts: Risk factors for HIV infection among young adult men in northern Thailand. Dynamics of risk behavior for HIV infection among young Thai men
  • Abstracts: Using a range of interventions to prevent falls in hospital. Brief interventions for people who drink heavily; health care professionals can intervene to educate clients on the risks of heavy drinking
  • Abstracts: Outside influence. Delivering on diabetes
  • Abstracts: Right side of the law. Supplementary prescribing for the elective surgical patient. MPs debate agency nurse rights
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.